These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

689 related articles for article (PubMed ID: 19074876)

  • 1. Coordinated regulation of cell cycle transcripts by p53-Inducible microRNAs, miR-192 and miR-215.
    Georges SA; Biery MC; Kim SY; Schelter JM; Guo J; Chang AN; Jackson AL; Carleton MO; Linsley PS; Cleary MA; Chau BN
    Cancer Res; 2008 Dec; 68(24):10105-12. PubMed ID: 19074876
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MicroRNA-34b and MicroRNA-34c are targets of p53 and cooperate in control of cell proliferation and adhesion-independent growth.
    Corney DC; Flesken-Nikitin A; Godwin AK; Wang W; Nikitin AY
    Cancer Res; 2007 Sep; 67(18):8433-8. PubMed ID: 17823410
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The miR-34 family in cancer and apoptosis.
    Hermeking H
    Cell Death Differ; 2010 Feb; 17(2):193-9. PubMed ID: 19461653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-122/cyclin G1 interaction modulates p53 activity and affects doxorubicin sensitivity of human hepatocarcinoma cells.
    Fornari F; Gramantieri L; Giovannini C; Veronese A; Ferracin M; Sabbioni S; Calin GA; Grazi GL; Croce CM; Tavolari S; Chieco P; Negrini M; Bolondi L
    Cancer Res; 2009 Jul; 69(14):5761-7. PubMed ID: 19584283
    [TBL] [Abstract][Full Text] [Related]  

  • 5. miR-181a and miR-630 regulate cisplatin-induced cancer cell death.
    Galluzzi L; Morselli E; Vitale I; Kepp O; Senovilla L; Criollo A; Servant N; Paccard C; Hupé P; Robert T; Ripoche H; Lazar V; Harel-Bellan A; Dessen P; Barillot E; Kroemer G
    Cancer Res; 2010 Mar; 70(5):1793-803. PubMed ID: 20145152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-34a: a novel tumor suppressor in p53-mutant glioma cell line U251.
    Luan S; Sun L; Huang F
    Arch Med Res; 2010 Feb; 41(2):67-74. PubMed ID: 20470934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of miR-34a on cell growth and chemoresistance in prostate cancer PC3 cells.
    Fujita Y; Kojima K; Hamada N; Ohhashi R; Akao Y; Nozawa Y; Deguchi T; Ito M
    Biochem Biophys Res Commun; 2008 Dec; 377(1):114-9. PubMed ID: 18834855
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A single recombinant adenovirus expressing p53 and p21-targeting artificial microRNAs efficiently induces apoptosis in human cancer cells.
    Idogawa M; Sasaki Y; Suzuki H; Mita H; Imai K; Shinomura Y; Tokino T
    Clin Cancer Res; 2009 Jun; 15(11):3725-32. PubMed ID: 19458054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis.
    Raver-Shapira N; Marciano E; Meiri E; Spector Y; Rosenfeld N; Moskovits N; Bentwich Z; Oren M
    Mol Cell; 2007 Jun; 26(5):731-43. PubMed ID: 17540598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 enters the microRNA world.
    Hermeking H
    Cancer Cell; 2007 Nov; 12(5):414-8. PubMed ID: 17996645
    [TBL] [Abstract][Full Text] [Related]  

  • 11. miR-335 directly targets Rb1 (pRb/p105) in a proximal connection to p53-dependent stress response.
    Scarola M; Schoeftner S; Schneider C; Benetti R
    Cancer Res; 2010 Sep; 70(17):6925-33. PubMed ID: 20713524
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Functional elucidation of MiR-34 in osteosarcoma cells and primary tumor samples.
    He C; Xiong J; Xu X; Lu W; Liu L; Xiao D; Wang D
    Biochem Biophys Res Commun; 2009 Oct; 388(1):35-40. PubMed ID: 19632201
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gene expression profiling of drug-resistant small cell lung cancer cells by combining microRNA and cDNA expression analysis.
    Guo L; Liu Y; Bai Y; Sun Y; Xiao F; Guo Y
    Eur J Cancer; 2010 Jun; 46(9):1692-702. PubMed ID: 20371173
    [TBL] [Abstract][Full Text] [Related]  

  • 14. miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer.
    Bandi N; Zbinden S; Gugger M; Arnold M; Kocher V; Hasan L; Kappeler A; Brunner T; Vassella E
    Cancer Res; 2009 Jul; 69(13):5553-9. PubMed ID: 19549910
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentially regulated micro-RNAs and actively translated messenger RNA transcripts by tumor suppressor p53 in colon cancer.
    Xi Y; Shalgi R; Fodstad O; Pilpel Y; Ju J
    Clin Cancer Res; 2006 Apr; 12(7 Pt 1):2014-24. PubMed ID: 16609010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-34a inhibits uveal melanoma cell proliferation and migration through downregulation of c-Met.
    Yan D; Zhou X; Chen X; Hu DN; Dong XD; Wang J; Lu F; Tu L; Qu J
    Invest Ophthalmol Vis Sci; 2009 Apr; 50(4):1559-65. PubMed ID: 19029026
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of miR-34a on protein output in hepatocellular carcinoma HepG2 cells.
    Cheng J; Zhou L; Xie QF; Xie HY; Wei XY; Gao F; Xing CY; Xu X; Li LJ; Zheng SS
    Proteomics; 2010 Apr; 10(8):1557-72. PubMed ID: 20186752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. MicroRNA-15b regulates cell cycle progression by targeting cyclins in glioma cells.
    Xia H; Qi Y; Ng SS; Chen X; Chen S; Fang M; Li D; Zhao Y; Ge R; Li G; Chen Y; He ML; Kung HF; Lai L; Lin MC
    Biochem Biophys Res Commun; 2009 Mar; 380(2):205-10. PubMed ID: 19135980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comprehensive assessment of p53-responsive genes following adenoviral-p53 gene transfer in Bcl-2-expressing prostate cancer cells.
    Spurgers KB; Coombes KR; Meyn RE; Gold DL; Logothetis CJ; Johnson TJ; McDonnell TJ
    Oncogene; 2004 Mar; 23(9):1712-23. PubMed ID: 14647426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. p53-independent upregulation of miR-34a during oncogene-induced senescence represses MYC.
    Christoffersen NR; Shalgi R; Frankel LB; Leucci E; Lees M; Klausen M; Pilpel Y; Nielsen FC; Oren M; Lund AH
    Cell Death Differ; 2010 Feb; 17(2):236-45. PubMed ID: 19696787
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.